| 000 | 01791 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516092700.0 | ||
| 264 | 0 | _c20130423 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1872-6844 | ||
| 024 | 7 |
_a10.1016/j.eplepsyres.2012.04.019 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKleinman, Nathan L | |
| 245 | 0 | 0 |
_aCosts, work absence, and adherence in patients with partial onset seizures prescribed gabapentin or pregabalin. _h[electronic resource] |
| 260 |
_bEpilepsy research _cNov 2012 |
||
| 300 |
_a13-22 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAmines _xeconomics |
| 650 | 0 | 4 |
_aAnticonvulsants _xeconomics |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xeconomics |
| 650 | 0 | 4 |
_aDatabases, Factual _xstatistics & numerical data |
| 650 | 0 | 4 |
_aDrug Costs _xstatistics & numerical data |
| 650 | 0 | 4 |
_aEpilepsies, Partial _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGabapentin |
| 650 | 0 | 4 |
_aHealth Expenditures _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 | _aPregabalin |
| 650 | 0 | 4 |
_aSick Leave _xeconomics |
| 650 | 0 | 4 |
_aWorkers' Compensation _xeconomics |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xanalogs & derivatives |
| 700 | 1 | _aSadosky, Alesia | |
| 700 | 1 | _aSeid, Jaren | |
| 700 | 1 | _aMartin, Roy C | |
| 700 | 1 | _aLabiner, David M | |
| 773 | 0 |
_tEpilepsy research _gvol. 102 _gno. 1-2 _gp. 13-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.eplepsyres.2012.04.019 _zAvailable from publisher's website |
| 999 |
_c21786801 _d21786801 |
||